The BMJ is an international peer reviewed medical journal and a fully "online first" publication. Our publishing model–"continuous publication"– means that all articles appear on bmj.com before being ...
A recent study, [1] conducted by three pharmacists and a nurse, explores why only 65% of patients with newly diagnosed type 2 diabetes (T2DM) and only 25% of people with ongoing T2DM are prescribed ...
CHAPEL HILL – Some doctors prescribe metformin, the most widely used type 2 diabetes treatment drug, for patients also suffering from congestive heart failure or kidney dysfunction or both despite ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Accumulating observational data suggest that metformin use in patients with type 2 diabetes might ...
(HealthDay News) — Concerns about safety of metformin in renal impairment may be unnecessarily preventing its use in type 2 diabetes mellitus (T2DM), according to a research letter published online ...
Metformin is one of the most common medications used to lower blood sugar in people with type 2 diabetes. It works by limiting the amount of glucose your liver releases and helping your cells use more ...
The Food and Drug Administration (FDA) has approved supplemental New Drug Applications (sNDA) for Invokana (canagliflozin) and Invokamet (canagliflozin/metformin HCl) tablets. The proposed sNDA ...
Glyburide, metformin HCl; 2.5mg/500mg, 5mg/500mg; tabs. Take with meals. Individualize. Not controlled on diet/exercise (use individual components): initially glyburide 1.25mg and metformin 250mg once ...
Study reveals a 35% increase in all-cause mortality risk compared with non-use. Metformin use by patients with stage 5 chronic kidney disease (CKD) may be an independent risk factor for early death, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback